Overview
Obizur is approved by the Food and Drug Administration (FDA) to control bleeding episodes in adults with acquired hemophilia. The technical name of Obizur is Antihemophilic factor (recombinant), porcine sequence.

How do I take it?
Prescribing information states that Obizur is given as an intravenous injection.

Obizur comes as a powder that must be reconstituted before injection.

Side effects
The FDA-approved label for Obizur lists common side effects including the development of inhibitors.

For more details about this treatment, visit:

Obizur prescribing information (PDF) – Baxalta.com... read more

Treatment of Hemophilia – Hemophilia Federation of America

Obizur (Antihemophilic factor [Recombinant], porcine sequence) Questions

Continue with Facebook
Sign up with your email
Already a Member? Log in
×

Welcome back!

Log in to gain access to the thousands of comments being shared on MyHemophiliaTeam.

log in
×